Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

PURPOSE: Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of early mortality (EM). In a multicenter randomized comparison against oral chemotherapy, autotransplantation was associated with 24% E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737858/
https://ncbi.nlm.nih.gov/pubmed/26371138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.4015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados